Previsioni di mercato delle particelle simili a virus nell\'Asia del Pacifico fino al 2028 - Impatto del COVID-19 e analisi regionale per tipo di prodotto (epatite, cancro/HPV e malattia di Gaucher), fonte (lievito, cellule di insetti, piante e altri) e applicazione (vaccini) e terapeutico)

Si prevede che il mercato delle particelle simili a virus nell\'Asia del Pacifico crescerà da 1.018,83 milioni di dollari nel 2021 a 1.769,02 di dollari milioni entro il 2028;si stima che crescerà a un CAGR dell\'8,2% dal 2021 al 2028.

Diversi attori del mercato sanitario e organizzazioni di ricerca sono attivamente coinvolti nelle innovazioni e nello sviluppo dei prodotti. L’uso di particelle simili a virus è un approccio emergente utilizzato nell’industria biofarmaceutica. Poiché le particelle simili a virus sono prive del contenuto virale, sono più facili da gestire rispetto ai componenti virali effettivi. I VLP possono essere utilizzati per facilitare la somministrazione di farmaci, l\'imaging, l\'immunoterapia e la terapia terapeutica. Ad esempio, secondo uno studio pubblicato dall\'NCBI nel giugno 2020, la VLP può essere utilizzata sotto forma di nanoparticelle in applicazioni quali terapia fototermica, imaging PET e TC, vettori di agenti di contrasto per MRI, imaging ottico, vaccini per malattie infiammatorie e autoimmuni, immunoterapia antitumorale e somministrazione di farmaci a piccole molecole (nella terapia antitumorale). Pertanto, si prevede che tali potenziali applicazioni dei VLP forniranno opportunità di crescita agli operatori del mercato durante il periodo di previsione.

Secondo il rapporto del Fondo monetario internazionale (FMI) , si prevedeva che la crescita nell\'Asia Pacifico sarebbe rimasta ferma allo zero% nel 2020. Si è trattato della peggiore performance di crescita in quasi 60 anni che ha coinvolto la crisi finanziaria globale (4,7%) e la crisi finanziaria asiatica (1,3%). Le revisioni al ribasso sono state sostanziali, variando dal 3,5% nel caso della Corea, ma sembrano essere riuscite a gestire la lenta diffusione del coronavirus a causa di interruzioni prolungate della produzione minimizzate che rappresentano il 9% in Australia, Nuova Zelanda e Tailandia. Questi paesi sono stati duramente colpiti dalla chiusura del turismo a livello mondiale e, nel caso dell’Australia, dal calo dei prezzi delle materie prime. L’Asia del Pacifico, dove sono attualmente in fase di sviluppo i vaccini contro il Covid-19, comprende Corea del Sud, Cina, Giappone, Tailandia e Vietnam. Tra questi, la Cina ha 15 vaccini, l’India e la Corea del Sud ne possiedono tre, il Giappone ha due vaccini e la Tailandia e il Vietnam ne hanno uno. Tra questi vaccini figurano dieci vaccini inattivati, sei vaccini a subunità proteica, sette vaccini a vettore virale e sei vaccini a base di acido nucleico. Inoltre, la promozione di un vaccino sicuro, equo ed efficace è una priorità assoluta nella regione dell’Asia del Pacifico. Secondo il rapporto della Banca asiatica di sviluppo, nel dicembre 2020, la Banca asiatica di sviluppo (ADB) ha lanciato un\'iniziativa di vaccini da 9 miliardi di dollari con l\'Asia Pacific Vaccine Access Facility (APVAX) che offrirà un supporto rapido ed equo ai paesi in via di sviluppo paesi (DMC) per procurarsi e fornire un vaccino COVID-19 efficace e sicuro. Attraverso la vaccinazione, è possibile interrompere la catena di trasmissione del virus, salvare vite umane e mitigare l\'impatto negativo della pandemia.

Con il nuovo caratteristiche e tecnologie, i fornitori possono attrarre nuovi clienti ed espandere la propria presenza nei mercati emergenti. È probabile che questo fattore guidi il mercato delle particelle simili ai virus nell’Asia del Pacifico. Si prevede che il mercato delle particelle simili a virus nell\'Asia del Pacifico crescerà a un buon CAGR durante il periodo di previsione.

Entrate e previsioni del mercato delle particelle simili a virus nell\'Asia del Pacifico fino al 2028 (milioni di dollari)

Segmentazione del mercato delle particelle simili a virus nell\'Asia del Pacifico

Mercato delle particelle simili a virus nell\'Asia del Pacifico - Per tipo di prodotto

Epatite
Cancro/HPV
Malattia di Gaucher

Mercato delle particelle simili a virus nell\'Asia del Pacifico - Per fonte

Lievito
Cellula di insetto
Impianti
Altri

Mercato delle particelle simili a virus nell\'Asia del Pacifico: – Per applicazione

Vaccini
Terapeutici

Mercato delle particelle simili a virus nell\'Asia del Pacifico - Per Paese

Mercato delle particelle simili a virus nell\'Asia Pacifico - Aziende citate

Merck & Co., Inc. ; \' bsp ;
GlaxoSmithKline plc.
Pfizer Inc. ; \' bsp ; ;
Sanofi ; ;
< span>Serum Institute of India Pvt. Ltd.
BHARAT BIOTECH ; \' bsp ;
LG Chem ; ;
Wantai BioPharm

1. Introduction

1.1 Scope of the Study

1.2 The Insight Partners Research Report Guidance

1.3 Market Segmentation

1.3.1 Asia Pacific Virus-like Particles Market – By Product Type

1.3.2 Asia Pacific Virus-like Particles Market – By Source

1.3.3 Asia Pacific Virus-like Particles Market – By Application

1.3.4 Asia Pacific Virus-like Particles Market – By Country

2. Asia Pacific Virus-like Particles Market – Key Takeaways

3. Research Methodology

3.1 Coverage

3.2 Secondary Research

3.3 Primary Research

4. Asia Pacific Virus-like Particles Market Landscape

4.1 Overview

4.2 PEST Analysis

4.3 Experts Opinion

5. Asia Pacific Virus-like Particles Market – Key Market Dynamics

5.1 Market Drivers

5.1.1 Surging Prevalence of Infectious Viral Diseases

5.1.2 Increasing Role of Virus-Like Particles in Therapeutic Developments and Studies

5.2 Market Restraints

5.2.1 Reach of Alternative Technologies for Viral Vaccine Production

5.3 Market Opportunities

5.3.1 Growing Potential Applications in Therapeutics and Diagnostics

5.4 Future Trends

5.4.1 Steady Demand for Innovative and Effective Products

5.5 Impact Analysis

6. Asia Pacific Virus-like Particles Market Analysis

6.1 Asia Pacific Virus-like Particles Market Revenue Forecast and Analysis

7. Asia Pacific Virus-like Particles Market Analysis – by Product Type

7.1 Overview

7.2 Asia Pacific Virus-like Particles Market, by Product Type, 2021 & 2028 (%)

7.3 Hepatitis

7.3.1 Overview

7.3.2 Hepatitis: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

7.4 Cancer/ Human Papillomavirus (HPV)

7.4.1 Overview

7.4.2 Cancer/HPV: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

7.5 Gaucher Disease

7.5.1 Overview

7.5.2 Gaucher Disease: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

8. Asia Pacific Virus-like Particles Market Analysis – By Source

8.1 Overview

8.2 Asia Pacific Virus-like Particles Market Share, by Source, 2021 & 2028 (%)

8.3 Yeast

8.3.1 Overview

8.3.2 Yeast: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

8.4 Plant

8.4.1 Overview

8.4.2 Plant: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

8.5 Insect Cell

8.5.1 Overview

8.5.2 Insect Cell: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

8.6 Others

8.6.1 Overview

8.6.2 Others: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

9. Asia Pacific Virus-like Particles Market Analysis – By Application

9.1 Overview

9.2 Asia Pacific Virus-like Particles Market Share, by Application, 2021 & 2028 (%)

9.3 Vaccines

9.3.1 Overview

9.3.2 Vaccine: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

9.4 Therapeutics

9.4.1 Overview

9.4.2 Therapeutics: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

10. Asia Pacific Virus-like Particles Market – Country Analysis

10.1 Overview

10.1.1 Asia Pacific: Virus-like Particles Market Revenue and Forecast to 2028, by Country (%)

10.1.1.1 Japan: Virus-Like Particles Market Revenue and Forecast to 2028 (US$ Million)

10.1.1.1.1 Overview

10.1.1.1.2 Japan: Virus-Like Particles Market Revenue and Forecast to 2028 (US$ Million)

10.1.1.1.3 Japan: Virus-Like Particles Market Revenue and Forecasts to 2028, by Product Type (US$ Million)

10.1.1.1.4 Japan: Virus-Like Particles Market Revenue and Forecasts to 2028, by Source (US$ Million)

10.1.1.1.5 Japan Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)

10.1.1.2 China: Virus-Like Particles Market Revenue and Forecast to 2028 (US$ Million)

10.1.1.2.1 Overview

10.1.1.2.2 China: Virus-Like Particles Market Revenue and Forecast to 2028 (US$ Million)

10.1.1.2.3 China Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)

10.1.1.2.4 China: Virus-Like Particles Market Revenue and Forecasts to 2028, by Source (US$ Million)

10.1.1.2.5 China Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)

10.1.1.3 India Virus-Like Particles Market Revenue and Forecast to 2028 (US$ Million)

10.1.1.3.1 Overview

10.1.1.3.2 India: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

10.1.1.3.3 India Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)

10.1.1.3.4 India Virus-like Particles Market, by Source - Revenue and Forecast to 2028 (US$ Million)

10.1.1.3.5 India Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)

10.1.1.4 South Korea: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

10.1.1.4.1 Overview

10.1.1.4.2 South Korea: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

10.1.1.4.3 South Korea Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)

10.1.1.4.4 South Korea Virus-like Particles Market, by Source - Revenue and Forecast to 2028 (US$ Million)

10.1.1.4.5 South Korea Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)

10.1.1.5 Australia: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

10.1.1.5.1 Overview

10.1.1.5.2 Australia: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

10.1.1.5.3 Australia Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)

10.1.1.5.4 Australia Virus-like Particles Market, by Source - Revenue and Forecast to 2028 (US$ Million)

10.1.1.5.5 Australia Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)

10.1.1.6 Rest of Asia Pacific: Virus-Like Particles Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.6.1 Overview

10.1.1.6.2 Rest of Asia Pacific: Virus-Like Particles Market – Revenue and Forecast to 2028 (US$ Million)

10.1.1.6.3 Rest of Asia Pacific Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)

10.1.1.6.4 Rest of Asia Pacific Virus-like Particles Market, by Source - Revenue and Forecast to 2028 (US$ Million)

10.1.1.6.5 Rest of Asia Pacific Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)

11. Impact Of COVID-19 Pandemic on Asia Pacific Virus-like Particles Market

11.1 Impact Assessment of COVID-19 Pandemic

12. Asia Pacific Virus-like Particles Market–Industry Landscape

12.1 Overview

12.2 Organic Developments

12.2.1 Overview

12.3 Inorganic Developments

12.3.1 Overview

13. Company Profiles

13.1 Merck & Co., Inc.

13.1.1 Key Facts

13.1.2 Business Description

13.1.3 Products and Services

13.1.4 Financial Overview

13.1.5 SWOT Analysis

13.1.6 Key Developments

13.2 GlaxoSmithKline plc.

13.2.1 Key Facts

13.2.2 Business Description

13.2.3 Products and Services

13.2.4 Financial Overview

13.2.5 SWOT Analysis

13.2.6 Key Developments

13.3 Pfizer Inc.

13.3.1 Key Facts

13.3.2 Business Description

13.3.3 Products and Services

13.3.4 Financial Overview

13.3.5 SWOT Analysis

13.3.6 Key Developments

13.4 Sanofi

13.4.1 Key Facts

13.4.2 Business Description

13.4.3 Products and Services

13.4.4 Financial Overview

13.4.5 SWOT Analysis

13.4.6 Key Developments

13.5 Wantai BioPharm

13.5.1 Key Facts

13.5.2 Business Description

13.5.3 Products and Services

13.5.4 Financial Overview

13.5.5 SWOT Analysis

13.5.6 Key Developments

13.6 Serum Institute of India Pvt. Ltd.

13.6.1 Key Facts

13.6.2 Business Description

13.6.3 Products and Services

13.6.4 Financial Overview

13.6.5 SWOT Analysis

13.6.6 Key Developments

13.7 BHARAT BIOTECH

13.7.1 Key Facts

13.7.2 Business Description

13.7.3 Products and Services

13.7.4 Financial Overview

13.7.5 SWOT Analysis

13.7.6 Key Developments

13.8 LG Chem

13.8.1 Key Facts

13.8.2 Business Description

13.8.3 Products and Services

13.8.4 Financial Overview

13.8.5 SWOT Analysis

13.8.6 Key Developments

14. Appendix

14.1 About The Insight Partners

14.2 Glossary of Terms

LIST OF TABLES

Table 1. Asia Pacific Virus-like Particles Market, Revenue and Forecast to 2028 (US$ Million)

Table 2. Japan: Virus-Like Particles Market Revenue and Forecasts to 2028, by Product Type (US$ Million)

Table 3. Japan: Virus-Like Particles Market Revenue and Forecasts to 2028, by Source (US$ Million)

Table 4. Japan Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)

Table 5. China Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)

Table 6. China: Virus-Like Particles Market Revenue and Forecasts to 2028, by Source (US$ Million)

Table 7. China Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)

Table 8. India Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)

Table 9. India Virus-like Particles Market, by Source - Revenue and Forecast to 2028 (US$ Million)

Table 10. India Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)

Table 11. South Korea Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)

Table 12. South Korea Virus-like Particles Market, by Source - Revenue and Forecast to 2028 (US$ Million)

Table 13. South Korea Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)

Table 14. Australia Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)

Table 15. Australia Virus-like Particles Market, by Source - Revenue and Forecast to 2028 (US$ Million)

Table 16. Australia Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)

Table 17. Rest of Asia Pacific Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)

Table 18. Rest of Asia Pacific Virus-like Particles Market, by Source - Revenue and Forecast to 2028 (US$ Million)

Table 19. Rest of Asia Pacific Virus-like Particles Market, by Application - Revenue and Forecast to 2028 (US$ Million)

Table 20. Organic Developments Done by Companies

Table 21. Inorganic Developments Done by Companies

Table 22. Glossary of Terms: Virus-like Particles Market

LIST OF FIGURES

Figure 1. Asia Pacific Virus-like particles Market Segmentation

Figure 2. Asia Pacific Virus-like particles Market Segmentation, By Country

Figure 3. Asia Pacific Virus-like Particles Market Overview

Figure 4. Hepatitis Held the Largest Share of the Product Type Segment in Asia Pacific Virus-like particles Market

Figure 5. India to Show Significant Growth during Forecast Period

Figure 6. Asia Pacific Virus-like Particles Market, Industry Landscape

Figure 7. Asia Pacific PEST Analysis

Figure 8. Asia Pacific Virus-like Particles Market: Impact Analysis of Drivers and Restraints

Figure 9. Asia Pacific Virus-like Particles Market– Revenue Forecast and Analysis to 2028

Figure 10. Asia Pacific Virus-like Particles Market, by Product Type, 2021 & 2028 (%)

Figure 11. Hepatitis: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

Figure 12. Cancer/HPV: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

Figure 13. Gaucher Disease: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

Figure 14. Asia Pacific Virus-like Particles Market Share, by Source, 2021 & 2028 (%)

Figure 15. Yeast: Virus-like Particles Market Revenue and Forecasts to 2028 (US$ Million)

Figure 16. Plant: Virus-like Particles Market Revenue and Forecasts to 2028 (US$ Million)

Figure 17. Insect Cell: Virus-like Particles Market Revenue and Forecasts to 2028 (US$ Million)

Figure 18. Others: Virus-like Particles Market Revenue and Forecasts to 2028 (US$ Million)

Figure 19. Asia Pacific Virus-like Particles Market Share, by Application, 2021 & 2028 (%)

Figure 20. Vaccine: Virus-like Particles Market Revenue and Forecasts to 2028 (US$ Million)

Figure 21. Therapeutics: Virus-like Particles Market Revenue and Forecasts to 2028 (US$ Million)

Figure 22. Asia Pacific Virus-like Particles Market Overview, by Country (2021)

Figure 23. Asia Pacific: Virus-like Particles Market Revenue and Forecast to 2028, by Country (%)

Figure 24. Japan: Virus-Like Particles Market Revenue and Forecast to 2028 (US$ Million)

Figure 25. China: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

Figure 26. India: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

Figure 27. South Korea: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

Figure 28. Australia: Virus-like Particles Market Revenue and Forecast to 2028 (US$ Million)

Figure 29. Rest of Asia Pacific: Virus-Like Particles Market – Revenue and Forecast to 2028 (US$ Million)

Figure 30. Impact of COVID-19 Pandemic in Asia Pacific Country Markets

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Asia Pacific virus-like particles market.
Highlights key business priorities in order to assist companies to realign their business strategies
The key findings and recommendations highlight crucial progressive industry trends in the Asia Pacific virus-like particles market, thereby allowing players across the value chain to develop effective long-term strategies
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
Scrutinize in-depth Asia Pacific market trends and outlook coupled with the factors driving the virus-like particles market, as well as those hindering it
Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution

Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement
Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports

Report Name	Published Date
Asia Pacific Wind Turbine Condition Monitoring Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Component (Hardware, and Software an..	May 2022
Asia Pacific Automotive System Simulation Software Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (Transmission, Engine, Elec..	May 2022
Asia Pacific Ground Engaging Tools Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Application (Excavators, Loaders, Bulldozers, an..	May 2022

Purchase Options

Single User License

$3000

$1800

Site License

$4000

$2400

Enterprise License

$5000